| Financial Year |
March 31 2023 |
| Monetary Funds |
4,260,320,807.23 |
| Held-for-trading Financial Assets |
1,683,123,009.89 |
| Notes Receivable |
1,618,795,224.87 |
| Accounts Receivable |
5,581,862,721.42 |
| Advances to Suppliers |
1,274,022,011.95 |
| Other Receivables |
167,749,693.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,134,658.73 |
| Dividend Receivable |
-- |
| Inventories |
5,391,348,014.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
851,490,809.15 |
| Other Current Assets |
598,142,919.91 |
| Total Current Assets |
21,855,775,132.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,534,822,415.02 |
| Long-term Equity Investment |
235,541,006.93 |
| Investment Properties |
-- |
| Fixed Assetes |
2,330,158,541.34 |
| Under-construction Projects |
1,263,058,387.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
901,788,380.18 |
| Intangible Assets |
805,392,996.76 |
| R&D expenses |
-- |
| Goodwill |
87,648,189.57 |
| Long-Term Deferred and Prepaid Expenses |
7,396,625.69 |
| Deferred Income Tax Assets |
292,801,948.90 |
| Other Non-Current Assets |
164,655,632.93 |
| Sub-Total of Non-Current Assets |
7,811,448,905.02 |
| Total Assets |
29,667,224,037.61 |
| Short-Term Loans |
1,806,565,407.32 |
| Trading Financial liabilities |
586,770.70 |
| Notes Payable |
2,529,482,692.12 |
| Accounts Payable |
2,333,404,056.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
191,186,542.47 |
| Taxes Payable |
251,001,200.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
410,479,979.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,185,529.31 |
| Other Current Liabilities |
1,264,699,017.78 |
| Sub-Total of Current Liabilities |
10,018,656,030.97 |
| Long-term Loans |
559,704,513.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
175,430,224.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
25,906,371.45 |
| Deferred Income Tax Liabilities |
352,988,724.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,195,013,404.43 |
| Total Liabilities |
11,213,669,435.40 |
| Paid-In Capital(Or Share Stock) |
1,026,952,941.00 |
| Capital Surplus |
6,288,782,884.59 |
| Surplus Reserve |
329,399,182.15 |
| LESS:Treasury Stock |
80,997,809.20 |
| Undistributed Profits |
10,212,811,728.18 |
| Minority Stockholder's Interest |
866,393,665.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,587,160,936.83 |
| Owner's Equity（Stockholder's Equity） |
18,453,554,602.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,667,224,037.61 |
